Stay updated with breaking news from Label Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FAIRFIELD (dpa-AFX) - GE Healthcare, the healthcare business of conglomerate General Electric Co. (GE), along with Lantheus Holdings Inc. (LNTH) announced Tuesday that the recent Phase III clinical
First line cohort of the Phase 1b/2 DEDUCTIVE study demonstrates promising efficacy and tolerability of tivozanib plus durvalumab in first line HCC Two...
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today presented a poster on Part 1, the open-label portion, of the study of SLS-002 at the IASRAFSP International Summit on Suicide Research Virtual Conference. The poster titled A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 ...
/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central...
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has been selected to present a poster on SLS-002 at the IASRAFSP International Summit on Suicide Research Virtual Conference, October 24-27 th 2021. Seelos will present the following in Poster Session 1 on Monday, October 25 th ...